Results 51 to 60 of about 15,314,245 (299)

Medication-related harm in New Zealand general practice: a retrospective records review

open access: yes, 2022
Background: The extent of medication-related harm in general practice is unknown.Aim: To identify and describe all medication-related harm in electronic general practice records.
Alesha J Smith (11908556)   +10 more
core   +2 more sources

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz   +12 more
wiley   +1 more source

How Clinical Integration of Pharmacists in General Practice has Impact on Medication Therapy Management: A Theory-oriented Evaluation

open access: yesInternational Journal of Integrated Care, 2019
Background: Data on medication-related hospital admissions suggest that there is an opportunity for improved pharmaceutical care. Hence, concerns about  medication-related hospital admissions is a driver to extend and integrate the role of community ...
Ankie C. M. Hazen   +6 more
doaj   +1 more source

A Review of the Toxicity of HIV Medications [PDF]

open access: yesJournal of Medical Toxicology, 2013
Antiretroviral therapy has changed human immunodeficiency virus (HIV) infection from a near-certainly fatal illness to one that can be managed chronically. More patients are taking antiretroviral drugs (ARVs) for longer periods of time, which naturally results in more observed toxicity. Overdose with ARVs is not commonly reported.
Asa M, Margolis   +3 more
openaire   +2 more sources

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani   +7 more
wiley   +1 more source

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben   +4 more
wiley   +1 more source

‘You get a different mindset’ – primary care physicians’ perceptions of interprofessional medication reviews for patients living independently

open access: yesScandinavian Journal of Primary Health Care
Objective In primary health care in southern Sweden, interprofessional medication reviews are conducted, to a limited extent, for patients living independently, with the purpose of optimising their pharmacological treatment. These medication reviews have
Annika Dobszai   +3 more
doaj   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

Artificial intelligence tool utilization in deprescribing practices among community pharmacists in Jordan: a cross-sectional study

open access: yesFrontiers in Digital Health
IntroductionData on artificial intelligence-supported deprescribing in Jordanian community pharmacy are still lacking. This study aimed to assess current deprescribing practices among community pharmacists in Jordan, identify the medication classes most ...
Ahmad Z. Al Meslamani   +4 more
doaj   +1 more source

Barriers to Medication Review Process Implementation—Cross-Sectional Study among Community Pharmacists in Jordan

open access: yes, 2022
The medication review process (MRP) is an extended, vital role of community pharmacists in improving health outcomes of medication use, yet it is neither systematically nor comprehensively provided bycommunity pharmacies in Jordan.
Hamza Alhamad   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy